Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UCB and UC-MSCs for Bone Marrow Failure Disorders
NCT05794425Phase 2Recruiting
- Sponsor
- Shandong Qilu Stem Cell Engineering
- Start
- Aug 2023
- Primary completion
- Apr 2025
- Modality
- Hematopoietic Stem Cells
- Countries
- 1
01
Overview
A Phase 2 trial of umbilical cord blood, human umbilical cord mesenchymal stem cells in bone marrow failure, sponsored by Shandong Qilu Stem Cell Engineering. Started Aug 2023; status: recruiting.
02
Drugs
umbilical cord bloodhuman umbilical cord mesenchymal stem cells
03
Conditions
bone marrow failure
Beyond the preview
Go deeper on NCT05794425.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05794425.